Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pancreatic safety of incretin-based drugs--FDA and EMA assessment.

× No keyword cloud information.

129 in total

Review 1. Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus.

Authors: Lesley J Scott
Journal: Drugs Date: 2014-12 Impact factor: 9.546

2. Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effects.

Authors: Martin Haluzík; Miloš Mráz; Štěpán Svačina
Journal: Drug Saf Date: 2014-12 Impact factor: 5.606

Review 3. Cardiovascular impact of drugs used in the treatment of diabetes.

Authors: Chris R Triggle; Hong Ding
Journal: Ther Adv Chronic Dis Date: 2014-11 Impact factor: 5.091

Review 4. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors: C Klemann; L Wagner; M Stephan; S von Hörsten
Journal: Clin Exp Immunol Date: 2016-05-13 Impact factor: 4.330

Review 5. A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?

Authors: Gaurav Chikara; Pramod Kumar Sharma; Pradeep Dwivedi; Jaykaran Charan; Sneha Ambwani; Surjit Singh
Journal: Indian J Clin Biochem Date: 2017-06-08

Review 6. Adverse Effects of GLP-1 Receptor Agonists.

Authors: Theodosios D Filippatos; Thalia V Panagiotopoulou; Moses S Elisaf
Journal: Rev Diabet Stud Date: 2015-02-10

Review 7. Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Authors: Gerhard H Scholz; Holger Fleischmann
Journal: Ther Adv Endocrinol Metab Date: 2014-10 Impact factor: 3.565

8. Author's reply to De Ponti et al.: "Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus".

Authors: André J Scheen
Journal: Clin Pharmacokinet Date: 2015-04 Impact factor: 6.447

9. Glucagonlike peptide 1 analogs in diabetes care.

Authors: Adrienne J Lindblad; Scott Garrison; G Michael Allan
Journal: Can Fam Physician Date: 2017-05 Impact factor: 3.275

10. Incretin-based therapy and pancreatitis: accumulating evidence and unresolved questions.

Authors: Yoshifumi Saisho
Journal: Ann Transl Med Date: 2018-04